| Entry |
|
|---|
| Name |
Sufentanil (USAN/INN) |
|---|
| Formula |
C22H30N2O2S
|
|---|
| Exact mass |
386.2028
|
|---|
| Mol weight |
386.5508
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
| Product (DG00793): | D00845<US> |
|
|---|
| Efficacy |
Analgesic (narcotic), Opioid receptor agonist |
|---|
| Comment |
Phenylpiperidine derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07224 | Opioid receptor agonists/antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N01 ANESTHETICS
N01A ANESTHETICS, GENERAL
N01AH Opioid anesthetics
N01AH03 Sufentanil
D05938 Sufentanil (USAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG02030 Anesthetics
DG02027 General anesthetics
DG02026 Opioid anesthetics
DG00793 Sufentanil
D05938 Sufentanil
DG01564 Opioid receptor agonist
DG01563 mu-Opioid receptor agonist
DG00793 Sufentanil
D05938 Sufentanil
Analgesic
DG01984 Opioid analgesics
DG00793 Sufentanil
D05938 Sufentanil
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Opioid
OPRM1
D05938 Sufentanil (USAN/INN)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D05938
Narcotics and psychotropics in Japan [br08308.html]
Narcotics by Cabinet Order Article 1 (157 substances)
D05938
Drug groups [BR:br08330]
Neuropsychiatric agent
DG02030 Anesthetics
DG02027 General anesthetics
DG02026 Opioid anesthetics
DG00793 Sufentanil
DG01564 Opioid receptor agonist
DG01563 mu-Opioid receptor agonist
DG00793 Sufentanil
Analgesic
DG01984 Opioid analgesics
DG00793 Sufentanil
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 27
1 C8x C 17.1577 -27.3913
2 C8x C 17.1577 -28.7920
3 C8x C 18.3707 -29.4924
4 C8x C 19.5838 -28.7920
5 C8y C 19.5838 -27.3913
6 C8x C 18.3707 -26.6909
7 N1c N 20.8155 -26.6799
8 C1z C 22.0213 -27.3760
9 C1x C 22.0217 -28.7916
10 C1x C 23.2350 -29.4916
11 N1y N 24.4479 -28.7909
12 C1x C 24.4474 -27.3752
13 C1x C 23.2342 -26.6752
14 C1b C 25.6567 -29.4883
15 C1b C 26.8492 -28.7993
16 C8y C 28.0393 -29.4859
17 C8x C 28.4502 -30.8231
18 C8x C 29.8542 -30.8454
19 C8x C 30.3092 -29.5171
20 S2x S 29.1866 -28.6738
21 C5a C 20.8152 -25.2903
22 O5a O 19.5903 -24.5833
23 C1b C 22.0163 -24.5965
24 C1a C 23.2069 -25.2837
25 C1b C 20.7784 -28.0939
26 O2a O 20.7784 -29.4947
27 C1a C 19.5823 -30.1854
BOND 29
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 8 13 1
15 11 14 1
16 14 15 1
17 15 16 1
18 16 17 2
19 17 18 1
20 18 19 2
21 19 20 1
22 16 20 1
23 7 21 1
24 21 22 2
25 21 23 1
26 23 24 1
27 8 25 1
28 25 26 1
29 26 27 1
|
|---|
